Amphastar Pharmaceuticals Cash from Investing (TTM) Analysis

Amphastar Pharmaceuticals Inc (AMPH)

40.91 +0.74 (+1.84%) USD | NASDAQ | Apr 23, 16:00

40.92 +0.01 (+0.02%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-649.12M
September 30, 2023	-546.30M
June 30, 2023	-530.40M
March 31, 2023	-30.00M
December 31, 2022	-32.78M
September 30, 2022	-44.50M
June 30, 2022	-33.01M
March 31, 2022	-29.09M
December 31, 2021	-28.67M
September 30, 2021	-28.89M
June 30, 2021	-30.58M
March 31, 2021	-36.39M
December 31, 2020	-36.42M
September 30, 2020	-31.59M
June 30, 2020	-44.76M
March 31, 2020	-44.36M
December 31, 2019	-50.53M
September 30, 2019	-51.97M
June 30, 2019	-46.23M
March 31, 2019	-48.33M
December 31, 2018	-42.18M

Date	Value
September 30, 2018	-43.51M
June 30, 2018	-43.61M
March 31, 2018	-39.66M
December 31, 2017	-36.89M
September 30, 2017	-33.87M
June 30, 2017	-35.87M
March 31, 2017	-36.05M
December 31, 2016	-39.50M
September 30, 2016	-36.85M
June 30, 2016	-25.59M
March 31, 2016	-21.30M
December 31, 2015	-16.92M
September 30, 2015	-22.39M
June 30, 2015	-21.82M
March 31, 2015	-40.02M
December 31, 2014	-39.77M
September 30, 2014	-33.01M
June 30, 2014	-34.96M
March 31, 2014	-15.97M
December 31, 2013	-18.30M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-649.12M

Minimum

Dec 2023

-28.67M

Maximum

Dec 2021

-122.40M

Average

-36.42M

Median

Dec 2020

Cash from Investing (TTM) Benchmarks